Skip to content Skip to footer


The fundamental B2B building blocks that companies need to succeed in the cannabis industry.


Our influential series of B2B conferences and expos bridge the gap between cannabis and the mainstream. They provide the platform for cannabis businesses, brands, investors and policymakers to connect, get deals done and build ongoing commercial relationships. These pivotal events are attended by thousands of delegates from over 50 countries annually.


Our reliable and credible data on commercial opportunities, market size and the regulatory environment in key cannabis markets globally provides our 300,000 monthly readers with actionable business insights. This global community also trusts our respected range of digital media titles to keep them informed on the latest industry developments through a variety of multimedia content.


Through technology, we’re removing many of the barriers preventing exponential growth for Europe’s cannabis industry and the businesses that operate within it. We’re powering cannabis commerce by providing a trusted space where buyers can make safe and informed purchases, and sellers can distinguish and grow their business. A space where product quality is obvious and payments are painless.

Data &

B2B Cannabis Technology

Media &

Events &

About Us

Prohibition Partners is the discovery platform for B2B cannabis with fully integrated solutions across conferences, content and commerce. The company was founded in 2017 with a vision for a legal cannabis industry where the abundant economic, societal and health benefits of the plant can be realised by people around the world.

Our Brands

Our portfolio includes some of the most widely used and respected brands in the global cannabis industry.


PRE-REGISTER | The Cannabis Technology Report
From agritech to point of sale systems, The Cannabis Technology Report provides a comprehensive analysis of the current technological landscape in the global cannabis industry. It offers insights into sector investments and guides operators on the benefits of existin...
PRE-ORDER | The German Cannabis Report
The German Cannabis Report provides an in-depth analysis of Germany's evolving cannabis market. The report examines the regulatory landscape, market potential, products and pricing, and future outlook. Key insights highlight the projected market growth, potential cha...
TECR9 Front Cover
The European Cannabis Report: 9th Edition
The 9th Edition of the longest-standing annual report dedicated to Europe's evolving and dynamic legal cannabis market is now available for pre-order. This report, endorsed by headline partner, Curaleaf Laboratories, amongst others, offers the most up-to-date insi...
The Canadian Cannabis Report
Economic dynamics have shifted over the past five years from favouring producers to buyers, leading to a recent shortage of low-grade biomass. Market share trends are adjusting as early entrants see declines and new operators focus on high-velocity products, streamli...
The Oceania Regulatory Report
The regulatory frameworks that Australia and New Zealand have developed for their respective legal cannabis industries share some top-level similarities; however, there are key differences, which could become more pronounced in the medium term as the two systems evol...
The Global Cannabis Report: 4th Edition
The Global Cannabis Report: 4th Edition provides the most comprehensive overview of, and analysis into, all major cannabis markets globally - broken down by region. It provides an overview of the development of cannabis markets at an international level and considers...

Principles of Clinical Cannabinology: A Comprehensive Guide to Medical Cannabis in Europe

Co-authored by Prohibition Partners and Cannabiscientia SA,  this publication is intended to be of support to European healthcare professionals, and all those interested in understanding the medical use of cannabis in Europe. In a single eBook, it provides a comprehensive overview of the science, regulations, medicine and products on the market.

Topics covered include the physiology of the endocannabinoid system, the pharmacology of cannabis and its clinical relevance for a number of pathologies. The Handbook also includes case studies and practical evidence of experienced prescribers around the globe that can serve as a guiding support in the obstacles of translating theory to practical applications.

Latest Insights

israel cannabis reform
January 31, 2024
New Reforms Set to Send Israeli Medical Cannabis Patient Numbers Soaring – Industry Growth to Follow
The number of Israeli patients using medical cannabis is set to soar by 2027, as imminent reforms will make it...
Israel cannabis
January 31, 2024
LAUNCHING TODAY | The Israeli Cannabis Report
Prohibition Partners are proud to announce the publication of The Israeli Cannabis Report.  This report delves into the intricate journey...
January 23, 2024
LAUNCHING TODAY | Oceania Regulatory Report
Prohibition Partners are proud to announce the publication of the Oceania Regulatory Report today. This report provides a current regulatory...
December 14, 2023
LAUNCHING TODAY | The Global Cannabis Report: 4th Edition
Prohibition Partners are proud to announce the publication of The Global Cannabis Report: 4th Edition. The legal cannabis industry in...

Events & Conferences

Cannabis Europa London

Location: London, UK

Date: 25-26 June, 2024

Join 1,500+ influential leaders from thriving cannabis companies, investors actively deploying capital into the market, plus key politicians — the crucial combination needed to drive the European cannabis industry and your business forward.

Business of Cannabis: New York

Location: New York, US

Date: TBC, 2024

Business of Cannabis: New York will once again bring together the most influential leaders in policy, business, law and finance together to focus on the new capital of cannabis: New York. Join us for the next instalment of BofCNY.

As Trusted By



on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.